Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
EX-99.1
This exhibit discloses the poll results of Hesai Group's Annual General Meeting held on June 26, 2026, including voting outcomes on seven ordinary resolutions covering financial statement adoption, director re-elections, auditor re-appointment, share issuance and repurchase mandates, and a material share subdivision (8-for-1 split effective July 10, 2026). The detailed voting tallies by share class and the passage of all resolutions constitute a shareholder_vote_results disclosure. The share subdivision is material to investors as it affects share structure and trading arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
Celldex held its Annual Meeting of Stockholders on June 25, 2026, with shareholders voting on four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, approval of an amendment to the 2021 Omnibus Equity Incentive Plan increasing available shares by 3.4 million, and advisory approval of named executive officer compensation. All proposals received tabulated voting results.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
Item 8.01
Southern Peru Copper Corporation (SPCC), a subsidiary of Southern Copper Corporation, issued US$1.25 billion in bonds through a New York market offering with a 5.35% annual interest rate maturing in 2036. This represents a material creation of direct financial obligation for the registrant and its subsidiary, disclosed under Item 8.01 as a press release announcement of the completed bond offering.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This Item 5.07 disclosure reports the results of CION's Annual Meeting of Shareholders held on June 25, 2026, including voting outcomes for two proposals: election of two board directors (Robert A. Breakstone and Catherine K. Choi) and ratification of RSM US LLP as independent auditor. The filing provides detailed vote tallies (votes for, withheld, against, abstentions, and broker non-votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-06-26
Item 8.01
The filing discloses the convening and adjournment of an extraordinary general meeting on June 26, 2026, where shareholders voted to approve an adjournment of the meeting to allow for a reconvened vote on a proposal to extend the date by which the Company must consummate an initial business combination. While the final vote on the Extension itself has not yet occurred (scheduled for the reconvened meeting at 3:00 p.m. the same day), the disclosure of the shareholders' approval of the adjournment proposal constitutes a shareholder vote result material to investors assessing the Company's timeline for completing its business combination.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-26
Item 1.01
SmartKem funded a $2.5 million convertible promissory note to Ferrox on June 22, 2026, creating a direct financial obligation with 5% interest, maturity on December 31, 2026, and conversion rights into Ferrox ordinary shares.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 3.02
SmartKem issued 5,000 shares of Series A convertible preferred stock and 10,753,615 warrants in a private placement on June 22, 2026, raising approximately $4.0 million in cash under Section 4(a)(2) and Regulation D Rule 506.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-26
Item 8.01
Soligenix increased the maximum aggregate offering amount under an At Market Issuance Sales Agreement (ATM offering) by an additional $2,500,000 of common stock. The company had previously sold approximately $6,234,000 under the same agreement. ATM offerings are a classic form of dilutive equity issuance used by smaller public companies to raise capital, and the prospectus supplement filing establishes the legal framework for this dilutive offering.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-26
Item 5.02
The filing discloses multiple compensatory arrangements approved by the HRCC effective June 24, 2026: (1) a TY26 annual cash incentive plan with target payouts ranging from 100–175% of base salary for six named executive officers; (2) a TY26–CY28 long-term equity program comprising PSUs and RSUs with target payouts of 200–450% of base salary; (3) Spin-Off bonuses (cash and RSUs) totaling up to $1 million for Mr. Smith; and (4) an Equity-Based Retirement Policy governing vesting treatment. These are core executive compensation matters within the scope of Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-06-26
Item 5.02
Ronald L. Sargent transitioned from Chief Executive Officer to Non-Executive Chairman with a new compensatory arrangement consisting of an annual retainer of $115,000 and incentive share grants valued at approximately $250,000.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
Kroger held its 2026 Annual Meeting of Shareholders on June 25, 2026, with shareholders voting on director elections (ten directors elected), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the Second Amended and Restated 2019 Long-Term Incentive Plan, and rejection of a shareholder proposal on GHG emissions reductions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-26
Item 5.07
This Item 5.07 disclosure reports the results of Navitas Semiconductor's 2026 annual meeting of stockholders held on June 25, 2026, including voting outcomes on four proposals: election of three directors, declassification of the board (which failed), advisory approval of executive compensation, and ratification of KPMG LLP as auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
Item 1.01
HA Sustainable Infrastructure Capital, Inc. issued $1,000,000,000 aggregate principal amount of 5.950% green senior unsecured notes due 2033 under an indenture dated June 24, 2026. This material debt issuance represents a significant capital-raising event and direct financial obligation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-26
Item 1.02
The filing discloses termination of a material business combination agreement between Israel Acquisitions Corp and Gadfin Ltd., originally entered into on January 26, 2025, and terminated on June 22, 2026. The agreement contemplated a series of merger transactions that would have resulted in both parties becoming wholly owned subsidiaries of a newly formed Israeli holding company. Termination of a material definitive agreement governing a proposed merger or acquisition is a core M&A activity event under Item 1.02.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
The 6-K discloses the results of Polestar's 2026 annual general meeting held on June 26, 2026, including voting outcomes on 16 resolutions covering financial statement approval, director re-appointments, auditor appointment (PwC replacing Deloitte AB), remuneration policies, and share issuance authorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, with detailed vote tallies and outcomes. The auditor change (Deloitte AB to PwC) is material but is disclosed as part of the AGM voting results rather than as a standalone auditor_change event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-06-26
Item 1.01
Cboe Global Markets entered into an Amendment and Restatement Agreement on June 23, 2026, to amend and restate a credit facility originally dated July 1, 2020, with an aggregate commitment of €1.2 billion (expandable to €1.7 billion via accordion increase) and an extended term to June 25, 2027. This material amendment to the Company's direct financial obligations constitutes a significant modification to its credit arrangements.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
The filing discloses the appointment of Michael L. Hammer to the Board of Directors of URSB Bancorp, Inc. and its bank subsidiary, effective July 29, 2026, with assignment to the Audit Committee and Nominating/Corporate Governance Committee. This is a clear executive appointment under Item 5.02, and board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
The filing discloses the issuance of $300,000,000 aggregate principal amount of 4.400% Fixed Rate Senior Notes due June 15, 2029, by John Deere Capital Corporation on June 26, 2026, pursuant to an automatic shelf registration statement. This is a material creation of a direct financial obligation and constitutes a debt issuance event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-06-26
EX-99.1
The announcement discloses a material amendment to the Brasília Airport concession agreement, including replacement of the fee structure, exit of a co-shareholder (Infraero), addition of 10 regional airports, and a mandatory competitive tender process for 100% of Inframerica shares by December 2026. These constitute material changes to the economic terms and control structure of a significant asset, triggering a potential change-of-control event through the required public tender process.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-06-26
Item 2.03
Iron Mountain completed a private offering of $1.5 billion in 6.250% Senior Notes due 2035 on June 26, 2026, under a new indenture with Computershare Trust Company N.A. as trustee. Net proceeds of approximately $1.48 billion will be used to repay revolving credit facility borrowings and for general corporate purposes, representing a significant capital structure event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-26
Item 1.01
The filing discloses entry into a material definitive agreement for the sale of substantially all of the Company's assets. On June 22, 2026, Charles & Colvard entered into an Asset Purchase Agreement (the "AJS Purchase Agreement") with AJS Creations, Inc., whereby AJS agreed to acquire the Company's specified assets and assume certain liabilities for $2,700,000 in cash, subject to Bankruptcy Court approval (which was granted on June 25, 2026). This constitutes a material acquisition/disposition transaction under Item 1.01, representing a fundamental change in the Company's structure and operations during its Chapter 11 bankruptcy proceeding.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-26
Item 8.01
Union Electric Company (Ameren Missouri) filed a $343 million annual revenue increase request with the Missouri Public Service Commission on June 26, 2026. This is a material regulatory filing involving rate base of $16.7 billion and requested return on equity of 10.25%, which would directly affect the company's future cash flows and earnings. While regulatory proceedings are operational/strategic in nature, this does not fit the specific categories of debt issuance, dividend distribution, workforce reduction, or material litigation—it is a significant regulatory capital recovery request that a reasonable investor would consider material to assessing the company's financial prospects.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
Daniel Bendheim's appointment to Chief Executive Officer and President effective July 1, 2026 is the principal disclosed action. While the filing also details compensatory arrangements (employment agreement with $850,000 base salary, bonus, RSU grants), the core event is the executive appointment to the top leadership role. This is material to investors as CEO appointments significantly affect company direction and governance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-26
Item 8.01
Capricor announced that the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will convene on July 29, 2026 to review the company's Biologics License Application (BLA) for Deramiocel, with a PDUFA target action date of August 22, 2026. This is a material regulatory milestone in the development of the company's lead product candidate for Duchenne muscular dystrophy, representing a significant step toward potential FDA approval. While not a completed approval or a specific operational event like a partnership or contract, this is a material regulatory development that would affect investor assessment of the company's near-term prospects.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-26
Item 5.07
Shareholders of SELECT MEDICAL HOLDINGS CORP voted on June 26, 2026 to approve the Merger Proposal to adopt the Agreement and Plan of Merger with Stallion Intermediate Corporation and Stallion MergerSub Corporation, with 99,005,011 votes in favor and 1,789,017 against, representing approval by over 79.88% of outstanding shares and over 76.64% of unaffiliated shares. The vote also addressed a non-binding advisory Compensation Proposal (52,322,733 for, 48,410,193 against) and an Adjournment Proposal (rendered moot).
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-26
Item 1.01
Graf Global Corp. entered into non-redemption agreements with shareholders on June 26, 2026, in connection with a proposed business combination with BIG3 HoldCo LLC. The Sponsor agreed to transfer 425,602 Founder Shares to non-redeeming shareholders to incentivize non-redemptions and preserve capital for the transaction's consummation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 90%
filed 2026-06-26
Item 5.07
Shareholders approved two proposals at a meeting held on June 26, 2026: (i) an Extension Amendment extending the initial business combination deadline from June 27, 2026 to September 27, 2026, with further discretionary extensions possible, and (ii) an Adjournment Proposal. The Extension Amendment received 21,123,642 votes in favor and 1,619,105 votes against.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-26
Item 3.01
The filing discloses a delisting notice under Item 3.01. Although the Company ultimately regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) and the delisting matter is now closed as of June 26, 2026, the disclosure documents the Company's prior failure to maintain the $1.00 minimum bid price for 30 consecutive business days (triggering the February 18, 2026 delisting notice) and its subsequent remediation. This is a material event affecting the registrant's listing status and investor confidence, even though the immediate delisting risk has been resolved.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-06-26
Item 5.02
The disclosure centers on compensatory arrangements for Jim Stephens, the Company's President of Cardiac Rhythm Management & Neuromodulation, including approval by the Compensation and Organization Committee of changes to his compensation in connection with a role transition to Executive Vice President, Special Projects, effective June 29, 2026, with a termination date of March 31, 2027, and exclusion from short-term and long-term incentive awards in 2027. While the filing also involves a role change, the principal disclosed action and the Committee's formal approval focus on the compensation modifications and severance-related terms (including the conditional "termination without Cause" treatment under the Change of Control Agreement), making this primarily a compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-26
Item 2.01
ProAssurance completed a merger in which Merger Sub merged with and into ProAssurance, with ProAssurance becoming a wholly owned subsidiary of The Doctors Company. ProAssurance shareholders received $25.00 per share in cash consideration, with all equity awards converted to cash payments at the same rate.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-26
Item 3.01
ProAssurance notified the NYSE on June 26, 2026 of the completion of the merger and requested suspension of trading and delisting of its common stock from the NYSE via Form 25 filing. The company intends to file Form 15 to terminate registration under Section 12(g) and suspend reporting obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-26
Item 3.03
ProAssurance disclosed a material modification to the rights of security holders by cross-reference to Items 2.01, 3.01, 5.01, and 5.03, relating to the merger completion, delisting, change of control, and governance amendments.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
The 6-K discloses results of GH Research PLC's annual general meeting held on June 25, 2026, where shareholders voted on and passed all board-recommended resolutions, including re-election of four directors (Florian Schönharting, Michael Forer, Dermot Hanley, and Duncan Moore) and ratification of PricewaterhouseCoopers Ireland as independent auditors. This is a classic shareholder vote result disclosure under Item 5.07 equivalent for foreign private issuers.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
BridgeBio held its Annual Meeting on June 22, 2026, with shareholders voting on five proposals: election of three Class I directors (James C. Momtazee, Frank P. McCormick, and Hannah A. Valantine), advisory approval of named executive officer compensation, annual frequency of say-on-pay votes, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2021 Stock Option and Incentive Plan increasing reserved shares by 2,000,000.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-26
EX-99.1
Ioneer received a conditional award from the U.S. Army for a long-term land lease at Tooele Army Depot to establish a critical mineral processing facility for boron. This is a material strategic partnership and operational milestone—one of only four companies selected—that secures a domestic supply chain for a critical mineral essential to national defense. While not a traditional M&A transaction, debt issuance, or earnings event, this represents a significant operational and commercial development that would affect a reasonable investor's assessment of the company's growth prospects and strategic positioning.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
Item 8.01
VeriSign entered into an underwriting agreement on June 18, 2026 to issue $550 million aggregate principal amount of 5.100% Senior Notes due 2031. This is a direct creation of a new financial obligation through a registered debt offering, with net proceeds of approximately $545 million expected to be used to redeem existing 4.750% Senior Notes due 2027. The disclosure of the underwriting agreement, registration statement, and indenture documents clearly indicates a material debt issuance event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
AES shareholders voted on June 26, 2026 at a special meeting to approve the proposed acquisition by a consortium led by Global Infrastructure Partners and EQT, with the merger proposal passing with 97.92% of votes cast in favor (479,072,642 votes). The transaction is valued at approximately $10.7 billion in equity value and $33.4 billion enterprise value, and the HSR Act waiting period expired on June 22, 2026, clearing a major regulatory condition for the acquisition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-06-26
Item 1.01
VeriSign completed a registered offering of $550 million aggregate principal amount of 5.100% Senior Notes due 2031 on June 26, 2026. This is a material creation of a new direct financial obligation under a supplemental indenture, clearly fitting the debt_issuance category. The substantial principal amount and senior unsecured status make this material to investors assessing the company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
Item 1.01
Allegiant issued $650 million in aggregate principal amount of 7.125% Senior Secured Notes due 2031 on June 24, 2026. The company used proceeds to repurchase $377.5 million of existing 7.25% notes due 2027 and for general corporate purposes, representing a material refinancing activity.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-26
EX-99.1
The exhibit is a press release announcing the results of Highlander Silver's annual general meeting of shareholders held on June 25, 2026. It discloses the approval of all matters presented, including the election of six directors and re-appointment of auditors, with detailed voting results for each director nominee. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and is material as it confirms the composition of the board of directors.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
EX-99.1
This press release discloses the voting results from Fury Gold Mines' Annual General Meeting held on June 25, 2026, including shareholder approval of: (1) fixing the board at six directors; (2) election of all six director nominees; (3) appointment of PricewaterhouseCoopers LLP as auditor; and (4) renewal of the long-term incentive plan for three years. The disclosure directly matches the `shareholder_vote_results` taxonomy entry, which covers results of votes at annual or special meetings of security holders. Board elections and auditor appointments are material governance matters affecting investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-06-26
EX-99.1
This is a notice announcing the forthcoming release of second quarter 2026 operating and financial results on July 28, 2026, with a conference call scheduled for July 29, 2026. While the actual results are not disclosed in this exhibit, the document is a press release announcing the timing and logistics of the earnings release event, which is a material disclosure to investors regarding when quarterly financial results will be publicly available.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-26
EX-99.1
This press release announces the results of Titan Mining's annual shareholders' meeting held on June 25, 2026. It discloses the approval of three matters: setting the board size at seven directors, election of all seven director nominees (with detailed voting results for each), and re-appointment of Ernst & Young LLP as auditors. The detailed vote tallies for each director nominee are the core disclosure, matching the shareholder_vote_results category precisely.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
EDAP TMS SA held its 2026 Annual General Meeting on June 26, 2026, with comprehensive shareholder voting results disclosed across 32 resolutions covering director elections, financial statement approvals, executive compensation advisory votes, capital delegation authorities, and bylaw amendments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
SCYNEXIS held its Annual Meeting of Stockholders on June 25, 2026, at which shareholders voted on and approved six proposals: election of directors, ratification of auditors, advisory votes on executive compensation, amendment to the equity incentive plan, and amendment to the Certificate of Incorporation to increase authorized shares.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-26
Item 8.01
An S-3 registration statement became effective for the resale of up to 87 million shares by selling stockholders, including 8.75 million shares from pre-funded warrants and 43.5 million shares from common warrants with a $1.20 exercise price, representing a substantial dilutive issuance to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 1.01
REalloys completed a private placement of 7,017,540 shares of common stock at $14.25 per share, raising approximately $100 million in gross proceeds. The unregistered shares were issued under Section 4(a)(2) and Rule 506(b) exemptions to institutional and accredited investors, with the company agreeing to file a resale registration statement.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 95%
filed 2026-06-26
Item 2.04
The Company received a notice of Event of Default from ADI Funding, LLC on June 11, 2026, asserting breach of the 8% secured promissory note ($271,739.13 principal) based on failure to file a resale registration statement, Form 8-K, and transfer agent instructions by the specified deadline. The Holder may exercise acceleration of debt, enforcement of collateral, and recovery of attorneys' fees if the default is not cured within ten trading days, triggering Item 2.04's requirement to disclose events that accelerate or increase direct financial obligations.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-06-26
EX-99.1
This exhibit is a written board resolution approving one-time performance bonuses for two named executives: Ms. Zhang Fan (Business Development Director) receives US$200,000 and Mr. Fu Xiaowei (CEO and Executive Director) receives US$300,000 for services rendered during 2025. The bonuses may be paid in cash or equivalent Class A ordinary shares. This is a direct disclosure of compensatory arrangements for named executives, fitting the exec_compensation category.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-06-26
KB Securities, a wholly-owned subsidiary of KB Financial Group, resolved on June 26, 2026 to increase its capital through issuance of 56,753,688 common shares at KRW 17,620 per share, generating approximately KRW 1 trillion in proceeds. This is a material capital raise by a significant subsidiary that will dilute existing shareholders' ownership and is disclosed as a discrete corporate action rather than a periodic financial report.
View raw filing on EDGAR →